Short answer
Danaher Corporation (DHR) filed an 8-K current report with the SEC on August 3, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Julie Sawyer Montgomery becomes CEO and director October 1, 2026, succeeding Rainer Blair after extensive Danaher operating experience.
Danaher Corporation 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Julie Sawyer Montgomery becomes CEO and director October 1, 2026, succeeding Rainer Blair after extensive Danaher operating experience
- CEO compensation: $1.5M salary, 200% target cash incentive, $13.2M 2027 long-term award
- Montgomery receives $20M time-vesting stock-option award, with 50% vesting in years four and five
- Blair remains Senior Advisor through December 31, 2026, then consultant through March 31, 2027, supporting leadership continuity
- Special awards extend retention incentives: CFO Matthew Gugino $12.5M, Christopher Riley $8M, Jose-Carlos Gutierrez-Ramos $2.625M
Item 7.01 · Regulation FD Disclosure
- Press release announces the leadership transition described in Item 5.02
- Exhibit 99.1 contains the company’s detailed transition announcement
- Leadership change may affect Danaher’s strategic execution and investor expectations
Item 8.01 · Other Events
- Special awards for each Rales: options on 1,000,000 shares plus RSUs on 500,000 shares
- Vesting: 50% on the fourth anniversary and 50% on the fifth anniversary, subject to continued employment
- Options: ten-year term with exercise price equal to Grant Date closing price
- Rales expected to remain in existing Board and executive roles, supporting strategic execution
- Stock compensation excluded from Adjusted Diluted EPS, with no change to third-quarter or full-year 2026 guidance
Item EX-99.1 · Exhibit EX-99.1
- Julie Sawyer Montgomery becomes CEO and board member October 1, 2026, marking a planned leadership succession
- Rainer Blair retires October 1 after six years as CEO, remaining senior advisor through March 31, 2027
- Diagnostics revenue grew from approximately $6.0B in 2017 to approximately $11.0B, with operating profit approximately tripling under Montgomery
- Special equity incentive awards for key leaders and founders may support retention but create potential dilution
- Third-quarter and full-year 2026 guidance unchanged, limiting immediate financial implications for investors
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Danaher Corporation 8-K filings
Get the next DHR 8-K as it lands
Follow DHR for push alerts, or ask the research agent what this filing means.